February 19, 2024 10:34 PM
NEW YORK – Pfizer’s drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission, the company said on Feb 19.
February 19, 2024 10:34 PM
NEW YORK – Pfizer’s drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission, the company said on Feb 19.